Bringing hope to bladder control


Urgency. Frequency. Leaks. Answer ten quick questions about bladder control and get one step closer to finding relief.

Signs of an overactive bladder

You may be all too familiar with signs of an overactive bladder. Do you:

  • Need to urinate frequently and urgently?
  • Use pads to control leaks?
  • Plan your life around the bathroom?

You might have an overactive bladder.

One in 6 adults suffers from bladder control problems.

One in six adults suffers from an overactive bladder.1,2

It’s time for
long-lasting relief.3

You know how disruptive incontinence can be. Maybe you‘ve tried diet changes, Kegel exercises, physical therapy, or medications, but the results weren’t what you hoped for. Don’t lose hope — there’s more you can do. Start by finding a bladder control specialist in your area who can help.

Women with symptoms often wait 6.5 years before being diagnosed.4

We offer a bladder control therapy that‘s different.

See how it works

Could the InterStim™
system help you?

No one wants to talk about bladder incontinence. But talking about it can
lead you to the right treatment.

Fill out our quiz, and tell us a little about your situation. Once we know more about your experiences, we‘ll send you some resources that can help you make an informed decision about your next steps.

Take the treatment quiz

These 10 quick questions get you one step closer to relief.

InterStim™ X neurstomulator with programmer


InterStim™ system for
long-term control3

InterStim™ is a small device implanted under the skin. You can test out an external version of the device first to help decide if it’s right for you.

Why InterStim™?


Satisfaction among those who use it.†7


Greater improvement in quality of life compared to medications.‡8


of people achieved success§ at 5 years.3


people worldwide have chosen the Medtronic InterStim™ system for more control3 and long-lasting relief.9

Sarah’s story

Sarah tried multiple treatments for incontinence, but she was still frequently excusing herself at work to rush to the bathroom. After InterStim™ therapy, she ran a half marathon with no issues.

See Sarah’s InterStim™ story.

Cautiously optimistic?

We get it. If you‘re curious to know more about testing for InterStim™, order a free info packet on the therapy and how you can take it for a test run — no strings attached.

Educational webinars

Register for a free, virtual event to learn about symptoms and treatments for conditions like overactive bladder. This is an opportunity to get answers directly from a doctor. Just pick an event date that works best for you.

Start the conversation

Unsure how to talk to your doctor about bladder control issues? Learn how to prepare for your appointment and important questions to ask about your therapy options.


Restored function defined as ≥50% reduction in dysfunctional voiding symptoms from baseline.

Reflects overactive bladder patients. The most common adverse events experienced during clinical studies included pain at implant sites, new pain, lead migration, infection, technical or device problems, adverse change in bowel or voiding function, and undesirable stimulation or sensations. Any of these may require additional surgery or cause return of symptoms.

Reflects OAB patients. The most common device-related adverse events in SNM subjects were undesirable change in stimulation 10.2% (6/59), implant site pain 8.5% (5/59), lead migration/dislodgment 3.4% (2/59), and implant site infection 3.4% (2/59). The MID (minimally important difference) is the smallest score change that is perceived beneficial to patients and is often used to determine whether changes in scores are considered clinically significant.


 Defined as a 50% or greater reduction in your troublesome bladder symptoms.


Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327–336.


US Census Bureau 2020. US adult and under-age-18 populations: 2020 census. Accessed June 20, 2022.


Siegel S, Noblett K, Mangel J, et al. Five-year follow-up results of a prospective, multicenter study of patients with overactive bladder treated with sacral neuromodulation.  J Urol. 2018;199(1):229–236.


Muller N. Overactive bladder in middle age women: the frustration of baby boomers with OAB symptoms. Ann Urol. 2010;1(1):1–8.


Leng WW, Morrisroe SN. Sacral nerve stimulation for the overactive bladder. Urol Clin N Am. 2006;33:491–501.


Chancellor MB, Chartier-Kastler EJ. Principles of sacral nerve stimulation (SNS) for the treatment of bladder and urethral sphincter dysfunctions. Neuromod. 2000;3(1):15–26.


Foster RT Sr, Anoia EJ, Webster GD, Amundsen CL. In patients undergoing neuromodulation for intractable urge incontinence a reduction in 24-hr pad weight after the initial test stimulation best predicts long-term patient satisfaction. Neurourol Urodyn. 2007;26:213–217.


Siegel S, Noblett K, Mangel J, et al. Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim™ therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder. Neurourol Urodyn. 2015;34:224–230. doi: 10.1002/nau.22544.


Medtronic InterStim™ Therapy Clinical Summary (2018).